Aw Flashcards

0
Q

How to increase profits 5

A

How can a company increase profit?

  • Reduce the time it takes to get on the market.
  • A better success rate of drugs going into trials.
  • Safety profile of the drug, more specific with less side effects speeds up the approval process.
  • Toxicity, lower this to reduce failure in clinical stage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Av time to market
Useful patent life
Patent life

A

Time to market - 14y
Patent life - 17y
5 are useful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

One in how many compounds makes it to market?

A

10000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tactics for making more specialised drugs and ensuring target is correct

A

Biopharm genomics and protein omits

Understanding the link between diseases, genetic makeup and expression of proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HTP

A

Screening up to 100000/day for activity against a protein target

Screening perhaps millions of compounds in a corporate collection to see if any show activity against a certain disease protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Virtual screening

A

Uses a PC to predict activity so you don’t need to make compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Combinatorial chem

A

Rapidly producing vast numbers of compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Molecular modelling

A

Computer models to improve activity, may be part of virtual screening

Allows visualisation of docking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is replacing animal testing and why? 2

A

In vitro and on silico testing (computer and tissue)

Faster, fewer ethical issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Three properties a drug needs

A

Chemical stability (shelf life)
Solubility (access to tissue)
pKa (soluble at ap pH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Biological properties a drug needs 6

A

Biodistribution (high conc at site of action)
Metabolism (where and into what? metabolites toxic before excretion?)
Half-life (correct form long enough for effect)
Potency (impacts dosing regime, higher doses = side-effects)
Specificity (ideally highly active against one protein)
Toxicity (Nein, danke)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bioisosteres

A

Structurally distinct molecular fragments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Framework is structural units that are 2

A

Metabolically inert and conformationallay restrained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is framework usually hydrocarbon?

A

Not soluble in water but very soluble in other shit ( such as other hydrocarbons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genomics defien

A

Genomics is fast-forwarding our understanding of how DNA, genes, proteins and protein function are related, in both normal and disease conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hops for genomics

A

Identify new targets and personalise therapies

16
Q

Gene chips

A

Allow is to look for changes in protein expression in different people/condition
And see if presence of drug changes that expression

17
Q

Biopharmacueticals

A

Drugs based on proteins, peptides or natural products instead of small molecules (chemistry)
Natural proteins already ‘designed’ to interact with receptors - cuts time to market in half

18
Q

Hts how many of the screened will have acitivty?

A

Maybe thousands in a collection of millions, chemist must select 2-3 to proceed

19
Q

Informatics implications 3

A

• Need to be able to store chemical structure and biological data for millions of datapoints – Computational representation of 2D structure
• Need to be able to organize thousands of active compounds into meaningful groups – Group similar structures together and relate to activity
• Need to learn as much information as possible from the data (data mining) – Apply statistical methods to the structures and related information

20
Q

Comb chem

A

By combining molecular “building blocks”, we can create very large numbers of different molecules very quickly.

• Usually involves a “scaffold” molecule, and sets of compounds which can be reacted with the scaffold to place different structures on “attachment points

21
Q

Which comb chem what later process is essential

A

HTS to test them all

22
Q

Comb chem issues

A
  • Which R-groups to choose
  • Which libraries to make – “Fill out” existing compound collection? – Targeted to a particular protein? – As many compounds as possible?
    • Computational profiling of libraries can help – “Virtual libraries” can be assessed on computer
23
Q

Vapour diffuse method

A

Hanging drop of protein solution will crystallize as water diffuses into half strength solution below

24
Q

3d visualisation

A

•X-ray crystallography and NMR Spectroscopy can reveal 3D structure of protein and bound compounds
Visualization of these “complexes” of proteins and potential drugs can help scientists understand the mechanism of action of the drug and to improve the design of a drug • Visualization uses computational “ball and stick” model of atoms and bonds, as well as surfaces • Stereoscopic visualization available

25
Q

Docking with a Genetic Algorith

A
Modelling with algorithm to optimise binding:
-Minimize energy
-Hydrogen bonding 
-,Hydrophobic interactions 
Can be used for virtual screening
26
Q

Connolly surface shows

A

Electrostatic potential

27
Q

What has the biggest impact in binding

A

Charge

28
Q

In vivo ADME model

A

Based around real tissue samples, which have similar properties to those in the body

29
Q

Example of in vivo ADME

A

CACO-2 tissue closely resembles the lining of the stomach, so if a molecule passes through CACO-2 it likely will also pass through the stomach lining, and thus be a candidate for oral delivery

30
Q

In silico ADME looks at…4

A

– LogP, a liphophilicity measure – Solubility – Permeability – Cytochrome p450 metabolism

31
Q

IV IV ADME help reduce

A

Attrition - failure in later stage